Stockreport

GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstract has [Read more]